Vest Financial LLC Boosts Stock Position in Colgate-Palmolive (NYSE:CL)

Vest Financial LLC grew its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 1.3% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 505,199 shares of the company's stock after acquiring an additional 6,244 shares during the period. Vest Financial LLC owned 0.06% of Colgate-Palmolive worth $52,445,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. Diversify Advisory Services LLC acquired a new stake in Colgate-Palmolive in the 1st quarter valued at about $911,000. TD Asset Management Inc raised its holdings in shares of Colgate-Palmolive by 2.4% in the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company's stock valued at $103,969,000 after purchasing an additional 26,987 shares during the last quarter. Empowered Funds LLC lifted its position in Colgate-Palmolive by 277.3% during the 1st quarter. Empowered Funds LLC now owns 33,082 shares of the company's stock worth $2,979,000 after buying an additional 24,314 shares in the last quarter. M&G Plc acquired a new position in Colgate-Palmolive during the first quarter valued at approximately $3,812,000. Finally, Sei Investments Co. grew its position in shares of Colgate-Palmolive by 41.5% in the 1st quarter. Sei Investments Co. now owns 598,639 shares of the company's stock valued at $53,901,000 after acquiring an additional 175,445 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Up 0.4 %

Shares of CL traded up $0.43 during mid-day trading on Friday, reaching $100.46. The company had a trading volume of 4,502,563 shares, compared to its average volume of 4,340,555. The stock has a market cap of $82.42 billion, a price-to-earnings ratio of 31.79, a price-to-earnings-growth ratio of 3.54 and a beta of 0.40. Colgate-Palmolive has a fifty-two week low of $71.46 and a fifty-two week high of $109.30. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.90. The firm has a fifty day simple moving average of $103.43 and a 200-day simple moving average of $97.66.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts' consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. During the same period in the previous year, the business earned $0.77 EPS. The business's quarterly revenue was up 4.9% on a year-over-year basis. On average, sell-side analysts anticipate that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 1.99%. Colgate-Palmolive's payout ratio is presently 63.29%.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company's stock, valued at $1,220,874.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the firm's stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the sale, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares of the company's stock, valued at $1,220,874.30. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 43,490 shares of company stock valued at $4,486,063. 0.34% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on CL shares. Jefferies Financial Group lowered Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their price objective for the company from $103.00 to $95.00 in a report on Wednesday, July 24th. Citigroup lifted their price target on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the stock a "buy" rating in a report on Wednesday, July 10th. Morgan Stanley raised their target price on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an "overweight" rating in a research note on Monday, July 29th. Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a "buy" rating to a "hold" rating and increased their target price for the stock from $107.00 to $109.00 in a report on Monday, September 9th. Finally, Evercore ISI raised their price target on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an "outperform" rating in a research report on Thursday, July 18th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of "Moderate Buy" and a consensus price target of $106.00.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.